Endopap®- versus Pipelle®-sampling in the diagnosis of postmenopausal endometrial disease
dc.contributor.author | Van Den Bosch T. | |
dc.contributor.author | Vandendael A. | |
dc.contributor.author | Wranz P.A.B. | |
dc.contributor.author | Lombard C.J. | |
dc.date.accessioned | 2011-05-15T16:16:22Z | |
dc.date.available | 2011-05-15T16:16:22Z | |
dc.date.issued | 1996 | |
dc.description.abstract | Objective: To evaluate the accuracy of Endopap®- and Pipelle®-sampling in the diagnosis of postmenopausal disease. Study Design: Observational study in the setting of a University Hospital. One hundred and six consecutive postmenopausal women presenting with uterine bleeding or endometrial cells on cervical cytology underwent an Endopap® sampling as well as a Pipelle® biopsy. Thereafter, 89 of those women underwent a hysteroscopy and curettage (n = 71) or a hysterectomy (n = 18). The diagnostic accuracy of Pipelle® and Endopap® was assessed against the final diagnosis. Results: Endometrial carcinoma was found in five cases (6%), benign disease in 34 (38%). The sensitivity of Endopap® and Pipelle® for the detection of endometrial disease was 56 and 51%, respectively, with a specificity of 94 and 100%, respectively. The sensitivity for endometrial carcinoma was 80% for Endopap® and 100% for Pipelle®. Conclusion: Our data tend to favor Pipelle® against Endopap® as diagnostic tool in endometrial disease in symptomatic postmenopausal women. | |
dc.description.version | Article | |
dc.identifier.citation | European Journal of Obstetrics Gynecology and Reproductive Biology | |
dc.identifier.citation | 64 | |
dc.identifier.citation | 1 | |
dc.identifier.issn | 03012115 | |
dc.identifier.other | 10.1016/0301-2115(95)02274-0 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13749 | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | cancer diagnosis | |
dc.subject | clinical trial | |
dc.subject | controlled clinical trial | |
dc.subject | controlled study | |
dc.subject | diagnostic accuracy | |
dc.subject | endometriosis | |
dc.subject | endometrium carcinoma | |
dc.subject | female | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | major clinical study | |
dc.subject | postmenopause | |
dc.subject | priority journal | |
dc.subject | sampling | |
dc.subject | biopsy | |
dc.subject | comparative study | |
dc.subject | differential diagnosis | |
dc.subject | endometrium | |
dc.subject | endometrium tumor | |
dc.subject | instrumentation | |
dc.subject | pathology | |
dc.subject | sensitivity and specificity | |
dc.subject | uterus bleeding | |
dc.subject | uterus disease | |
dc.subject | Biopsy | |
dc.subject | Diagnosis, Differential | |
dc.subject | Endometrial Neoplasms | |
dc.subject | Endometrium | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Postmenopause | |
dc.subject | Sensitivity and Specificity | |
dc.subject | Uterine Diseases | |
dc.subject | Uterine Hemorrhage | |
dc.title | Endopap®- versus Pipelle®-sampling in the diagnosis of postmenopausal endometrial disease | |
dc.type | Article |